摘要
背景:干细胞疗法被确立为一种有前景的再生医学应用,如心脏修复。然而,目前基于干细胞的治疗策略具有严重的挑战,例如受损心肌中移植的干细胞的低保留和活力。这显着限制了干细胞疗法的效率。此外,关于移植后干细胞的命运和存活的知识不足是最近临床研究结果相互矛盾的主要原因。 目的:回顾的目的是突出纳米粒子在利用干细胞进行心脏修复的治疗方法中的关键特性和可能的应用。 结果:广泛用于各种生物医学应用的纳米颗粒可以作为克服这些障碍的有价值的工具。各种类型的纳米颗粒可以有效地用于递送增强存活和再生能力的基因,并减少移植干细胞在不利缺血微环境中的凋亡。此外,用化学试剂和/或特定蛋白质和肽修饰纳米颗粒极大地增加了有针对性地转移货物的可能性。纳米颗粒还可以极大地促进干细胞追踪的体内监测。使用多模态杂化纳米化试剂,可以获得干细胞移植物的移植后行为的详细表征。 结论:使用纳米载体可能对触发心血管干细胞生物学的效率非常有帮助。然而,重要的是要牢记纳米粒子的实施安全性和兼容性,以进行临床试验
关键词: 纳米粒子,干细胞疗法,干细胞追踪,基因增强,心脏修复,推定应用。
图形摘要
Current Drug Targets
Title:Engineered Nanoparticles: Their Properties and Putative Applications for Therapeutic Approaches Utilizing Stem Cells for the Repair of Atherosclerotic Disease
Volume: 19 Issue: 14
关键词: 纳米粒子,干细胞疗法,干细胞追踪,基因增强,心脏修复,推定应用。
摘要: Background: Stem cell therapy was established as a promising approach for regenerative medicine applications such as cardiac repair. However, current stem cell-based therapeutic strategies have serious challenges such as low retention and viability of transplanted stem cells in the injured myocardium. This significantly limits efficiency of stem cell therapy. In addition, poor knowledge about the fate and survival of stem cells after transplantation represents a major reason of conflicting results from recent clinical studies.
Objective: The purpose of review is to highlight key properties and possible applications of nanoparticles for therapeutic approaches utilizing stem cells for cardiac repair.
Results: Nanoparticles that are widely used in various biomedical applications may serve as a valuable tool for overcoming these obstacles. Various types of nanoparticles could be efficiently used for delivery of genes that enhance survival and regenerative capacity and decrease apoptosis of transplanted stem cells in the adverse ischemic microenvironment. Furthermore, modification of nanoparticles with chemical agents and/or specific proteins and peptides greatly increases the possibility of targeted transfer of a cargo. Nanoparticles can also greatly facilitate in vivo monitoring of stem cell tracking. Using multimodality hybrid nanosized agents, it is possible to obtain detailed characterization of the post-transplantation behavior of stem cell engrafts.
Conclusion: Using of nanocarriers may be very helpful to trigger the efficiency of cardiovascular stem cell biology. It is important however to keep in the mind safety and compatibility of implementation of nanoparticles to proceed to clinical trials.
Export Options
About this article
Cite this article as:
Engineered Nanoparticles: Their Properties and Putative Applications for Therapeutic Approaches Utilizing Stem Cells for the Repair of Atherosclerotic Disease, Current Drug Targets 2018; 19 (14) . https://dx.doi.org/10.2174/1389450118666171027111528
DOI https://dx.doi.org/10.2174/1389450118666171027111528 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers